1-TRC105 is a Phase 2 monoclonal antibody that binds CD105 (endoglin), a membrane receptor on endothelial cells that is required for angiogenesis; it....
There’s no risk. Start your trial today to see profiles of TRACON Pharmaceuticals (aka TRACON PHARMA) plus 5517 other startups.
Start Free 7 Day Trial Now
